RobertWKleinMD

PubMed

• 15 citations
  Multimodal imaging of bilateral diffuse uveal melanocytic proliferation associated with an iris mass lesion
  Jonathan Naysan, Claudine E. Pang, Robert W. Klein, K. Bailey Freund> ;International Journal of Retina and Vitreous. 2016 May 16
• The Cost-Effectiveness of Duloxetine in Chronic Low Back Pain: A US Private Payer Perspective-Author Response to Letter to the Editor.
  Wielage, R. C.,Bansal, M.,Scott Andrews, J.,Wohlreich, M. M.,Klein, R. W.,Happich, M.> ;Value Health. 2013 Dec 12
• Use of a decision tree model to estimate the economic benefits of reducing schizophrenia illness relapse.
  Furiak, N.,Klein, R. W.,Gahn, J. C.,Camper, S. B.,Summers, K.> ;Value Health. 2013 May 23
• A model framework evaluating factors affecting the value of treatment one year following an acute coronary syndrome event.
  Ariely, R.,Klein, R.,Gahn, J. C.,Tham, W. K.,Cohen, D.,Bell, C.,Tynan, A.> ;Value Health. 2013 May 23
• Using Common Random Numbers in Health Care Cost-Effectiveness Simulation Modeling.
  Murphy, D. R.,Klein, R. W.,Smolen, L. J.,Klein, T. M.,Roberts, S. D.> ;Health Serv Res. 2013 Aug
• Building of an empire.
  Yale L. Fisher, John A. Sorenson, Jason S. Slakter, Richard S. Spaide, K. Bailey Freund, Robert W. Klein> ;Retina. 2012 Feb 1
• Screening and treatment for Alzheimer's disease: Predicting population-level outcomes.
  Furiak, N.M., Kahle-Wrobleski, K., Callahan, C., Klein, T.M., Klein, R.W., Siemers, E.R.> ;Alzheimers Dement. 2012 Jan
• 20 citations
  Longer-term outcomes of a prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.
  Louis K. Chang, Richard F. Spaide, James M. Klancnik, John A. Sorenson, Jason S. Slakter, K. Bailey Freund, Lawrence A. Yannuzzi, Joseph J. Tseng, Robert W. Klein> ;Retina. 2011 May 1
• Prevalence of respiratory syncytial virus (RSV) risk factors and cost implications of immunoprophylaxis to infants 32 to 35 weeks gestation for health plans in the Uni...
  Krilov, L.R., Palazzi, D.L., Fernandes, A.W., Klein, R.W., Mahadevia, P.J.> ;Value Health. 2010-01-01
• Tocolytic therapy: a meta-analysis and decision analysis.
  Haas, D.M., Imperiale, T.F., Kirkpatrick, P.R., Klein, R.W., Zollinger, T.W., Golichowski, A.M.> ;Obstet Gynecol. 2009 Mar
• 132 citations
  Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.
  Richard F. Spaide, Louis K. Chang, James M. Klancnik, Lawrence A. Yannuzzi, John A. Sorenson, Jason S. Slakter, K. Bailey Freund, Robert W. Klein> ;American Journal of Ophthalmology. 2009 Feb 1
• Development, validation, and application of a microsimulation model to predict stroke and mortality in medically managed asymptomatic patients with significant carotid...
  Smolen, H.J., Cohen, D.J., Samsa, G.P., Toole, J.F., Klein, R.W., Furiak, N.M., Lorell, B.H.> ;Value Health. 2007-11-01
• Cost-effectiveness analysis of variceal ligation vs. beta-blockers for primary prevention of variceal bleeding.
  Imperiale, T.F., Klein, R.W., Chalasani, N.> ;Hepatology. 2007 Apr
• Cost-effectiveness of tamsulosin, doxazosin, and terazosin in the treatment of benign prostatic hyperplasia.
  Ohsfeldt, R.L., Kreder, K.J., Klein, R.W., Chrischilles, E.A.> ;J Manag Care Pharm. 2004-09-01
• Measuring the hemodynamic response to primary pharmacoprophylaxis of variceal bleeding: a cost-effectiveness analysis.
  Imperiale, T.F., Chalasani, N., Klein, R.W.> ;Am J Gastroenterol. 2003 Dec
• Join now to see all